GH Optimization Research Kit — Complete Growth Hormone Axis Research
The GH Optimization Research Kit is an institutional growth-hormone-axis research procurement kit combining GHRH analogue (CJC-1295), selective GHRP (Ipamorelin), non-selective GHRP (GHRP-6), and second GHRH analogue (Sermorelin) for comprehensive GHRH/GHRP pathway research within a single institutional procurement.
Research Mechanism Coverage
The four-compound combination enables co-administration research across both GHRH receptor activation (CJC-1295 sustained + Sermorelin pulsatile) and GHS-R1a activation (Ipamorelin selective + GHRP-6 non-selective) — covering the major GH-axis research peptide classes within a single procurement.
Configuration Options
- Standard ($520): CJC 10mg + Ipa 10mg + GHRP-6 10mg + Sermorelin 5mg, x2 each
- Advanced ($895): x4 of each compound
- Extended Protocol ($1,650): x8 of each compound
Institutional minimum $500. Custom configurations available.
Research Use Only. For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing you confirm research-only intent. These products have not been evaluated by the FDA.
For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing you confirm research-only intent.



